Quality of life in sarcoidosis
Catharina C. Moor, Ogugua Ndili, Vivienne Kahlmann et al.
Research Article — Peer-Reviewed Source
Original research published by Moor et al. in Journal of Autoimmunity. Redistributed under Open Access — see publisher for license terms. MedTech Research Group provides these references for informational purposes. We do not conduct original research. All studies are the work of their respective authors and institutions.
Having sarcoidosis often has a major impact on quality of life of patients and their families. Improving quality of life is prioritized as most important treatment aim by many patients with sarcoidosis, but current evidence and treatment options are limited. In this narrative review, we describe the impact of sarcoidosis on various aspects of daily life, evaluate determinants of health-related quality of life (HRQoL), and provide an overview of the different patient-reported outcome measures to assess HRQoL in sarcoidosis. Moreover, we review the current evidence for pharmacological and non-pharmacological interventions to improve quality of life for people with sarcoidosis.
Full text is available at the publisher.
Read at Publisher| DOI | 10.1016/j.jaut.2023.103123 |
| Journal | Journal of Autoimmunity |
| Year | 2023 |
| Authors | Catharina C. Moor, Ogugua Ndili, Vivienne Kahlmann, Katharina Buschulte, Marlies Wijsenbeek |
| License | Open Access — see publisher for license terms |
| Citations | 7 |